UroGen Pharma

-$0.22 (-2.81%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.

About URGN

UroGen Pharma Ltd. is a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases. It has developed RTGel reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs.

CEO
Elizabeth Barrett
Employees
187
Headquarters
Princeton, New Jersey
Founded
2004

URGN Key Statistics

Market cap
170.62M
Price-Earnings ratio
—
Dividend yield
—
Average volume
139.36K
High today
$7.97
Low today
$7.49
Open price
$7.69
Volume
120.68K
52 Week high
$28.20
52 Week low
$7.46

URGN News

Simply Wall StJan 20

Further weakness as UroGen Pharma drops 12% this week, taking three-year losses to 84%

As every investor would know, not every swing hits the sweet spot. But really big losses can really drag down an overall portfolio. So take a moment to sympathi

URGN Earnings

-$1.58
-$1.05
-$0.53
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 17, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure